Drug Pricing Analysis: ICER’s Launch Pric...

By João L. Carapinha

May 20, 2025

The Institute for Clinical and Economic Review (ICER) has published the protocol for its first annual "Launch Price and Access Report." This essential drug pricing analysis evaluates launch prices and patient access to FDA-approved drugs from 2022...

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.